Skandanana Pharma Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Skandanana Pharma Private Limited

Skandanana Pharma Private Limited, a active private limited company, was established on 01 April 2020 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U93000TG2020PTC140032. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Nagendra Kumar Vallamkonda (Director), Vallamkonda Lakshmi Sravani (Director). It holds ₹1.99 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Plot No.46&47,2Nd Floor,Survey No.152,153&154,155 Blockno.167,Pragathinagar,Bachpally,Malk, Ajgiri, Hyderabad, Telangana, 500090.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U93000TG2020PTC140032

  • Registration Number

    140032

  • Incorporation Date

    01 April 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 1.99 Cr
  • Revenue Growth **** 6.87%
  • Profit Growth **** -242.93%
  • Ebitda **** -198.83%
  • Net Worth -119.22%
  • Total Assets **** 90.32%
Company report

Skandanana Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Skandanana Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Skandanana Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nagendra Kumar Vallamkonda Director 01 Apr 2020 Current
Vallamkonda Lakshmi Sravani Director 01 Apr 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skandanana Pharma.

Skandanana Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.87% increase. The company also saw a substantial fall in profitability, with a 242.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 119.22%.

Skandanana Pharma revenue growth over time
Skandanana Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 6.87%
*******
*******
*******
*******
Revenue from Operations
*******
 6.87%
*******
*******
*******
*******
Total Assets
*******
 90.32%
*******
*******
*******
*******
Profit or Loss
*******
 -242.93%
*******
*******
*******
*******
Net Worth
*******
 -119.22%
*******
*******
*******
*******
EBITDA
*******
 -198.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skandanana Pharma?

Unlock access to Skandanana Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹19,900,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 1.99 Cr
Latest Charge Details
Date Lender Amount Status
17 Jan 2023 Others ₹1.99 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Skandanana Pharma?

Unlock and access historical data on people associated with Skandanana Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skandanana Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skandanana Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skandanana Pharma
Recent Activity within the Organization
  • Charges

    The activity A charge with Others of Rs. 19.90 M registered on 17 Jan 2023 with Charge ID 100696699 was modified on 11 Jan 2024. was completed.

  • Annual General Meeting

    Progress on Skandanana Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Skandanana Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 19.90 M with Charge ID 100696699 was registered on 17 Jan 2023. was documented.

  • Director Appointment

    Progress on Nagendra Kumar Vallamkonda was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 10 months . was documented.

  • Director Appointment

    Vallamkonda Lakshmi Sravani was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 10 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Skandanana Pharma Private Limited?

The CIN of Skandanana Pharma Private Limited is U93000TG2020PTC140032.

Where is Skandanana Pharma Private Limited headquartered?

Skandanana Pharma Private Limited is headquartered at Plot No.46&47,2Nd Floor,Survey No.152,153&154,155 Blockno.167,Pragathinagar,Bachpally,Malk, Ajgiri, Hyderabad, Telangana, 500090.

When was Skandanana Pharma Private Limited incorporated?

Skandanana Pharma Private Limited was incorporated on 01 April 2020.

Who are the current directors of Skandanana Pharma Private Limited?

The current directors of Skandanana Pharma Private Limited are

What is the primary industry of Skandanana Pharma Private Limited?

The primary industry of Skandanana Pharma Private Limited is Hospital And Medical Care.

Is Skandanana Pharma Private Limited a listed company?

Skandanana Pharma Private Limited is unlisted.

What is the capital structure of Skandanana Pharma Private Limited?

The authorized capital of Skandanana Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available